October 25, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
October 24, 2022 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a ...
October 20, 2022 — A new highly selective PET imaging agent can detect the presence of overexpressed monoamine oxidase-B ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
October 19, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
October 17, 2022 — At the European Association of Nuclear Medicine (EANM) Annual Meeting, GE Healthcare proudly ...
September 28, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
September 28, 2022 — Xoran Technologies is engaged in a ground-breaking research project to develop a PET/CT scanner for ...
September 13, 2022 — For over 40 years the vision of Shared Medical Services (SMS) has been to provide innovative ...
September 8, 2022 — In prostate cancer patients experiencing recurrence following a radical prostatectomy, imaging with ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to ...
August 30, 2022 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT), a ...
July 20, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
July 19, 2022 — Radialis Inc. today announced that it has received clearance to market the Radialis PET Imager, an organ ...
July 11, 2022 — The "Molecular Imaging Market, by Application (Cancer, Heart Disease, Brain Disorder), by Technology ...
July 11, 2022 – The American Society of Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular ...
July 6, 2022 — Lung cancer is the most common cancer in the world, with 2.2 million new cases and around 1.8 million ...
June 29, 2022 — Siemens Healthineers and The Ohio State University Wexner Medical Center announced a new alliance, aimed ...
June 22, 2022 — Andrei Iagaru, MD, FACNM, professor of radiology (nuclear medicine) and chief of the Division of Nuclear ...
June 21, 2022 — Markus Schwaiger, MD, a scientist known for his contributions to cardiac PET imaging, has been named as ...
June 15, 2022 — Poor functional outcomes after a heart attack can be predicted with a new PET imaging agent, 68Ga-FAPI ...